Targeted Temperature Management After Cardiac Arrest
Targeted Temperature Management After Cardiac Arrest
复制标题
DOI：
10.1007/978-3-319-71712-8_14
复制
发表时间：
2018
期刊：
影响因子：
--
通讯作者：
Cindy H. Hsu;Hasan B. Alam
中科院分区：
文献类型：
--
作者：
Cindy H. Hsu;Hasan B. Alam
心脏骤停是美国和全球的主要死亡原因之一。尽管最近心肺复苏取得了进展，但心脏骤停的存活率仍然很低。靶向体温管理（TTM）或治疗性低温已被证明可以改善昏迷心脏骤停幸存者的生存和功能结局。本章将重点介绍成人非创伤性心脏骤停后TTM的病理生理学和实际考虑。TTM的适应症，实施和副作用在这里进行了讨论，以帮助读者在其应用程序在逮捕后的管理。
Cardiac arrest is one of the leading causes of death in the United States and globally. Despite recent advancements in cardiopulmonary resuscitation, the survival rate of cardiac arrest remains low. Targeted temperature management (TTM), or therapeutic hypothermia, has been shown to improve the survival and functional outcome of comatose cardiac arrest survivors. This chapter will focus on the pathophysiology and practical considerations of TTM after adult non-traumatic cardiac arrest. The indications, implementation, and side effects of TTM are discussed here to assist readers in its application during post-arrest management.